Plain-English translation of NCT07215715 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a new ultrasound device called eMyosound LYRA that can measure how stiff your heart muscle has become. This study will help doctors understand whether this device can reliably detect heart stiffness in people with different types of heart failure, which could help with diagnosis and treatment in the future.
Certain types of heart failure involve the heart muscle becoming stiff, which makes it harder for the heart to work properly. Right now, doctors don't have a simple, reliable way to measure this stiffness, so this new ultrasound device could fill an important gap in how we diagnose and understand these conditions.
You likely qualify if…
You likely don't qualify if…
You will come for a single visit lasting about 2.5 hours at one of three medical centers. During this visit, you will have an ultrasound scan of your heart and liver using the new eMyosound LYRA device—this is painless and non-invasive. The ultrasound will measure how stiff your heart muscle is, and the same scan will be done twice by different technicians to make sure the device gives reliable results each time.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States